{"id":535876,"date":"2021-09-08T16:08:57","date_gmt":"2021-09-08T20:08:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/"},"modified":"2021-09-08T16:08:57","modified_gmt":"2021-09-08T20:08:57","slug":"tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/","title":{"rendered":"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>AUSTIN, Texas, Sept.  08, 2021  (GLOBE NEWSWIRE) &#8212; TFF Pharmaceuticals, Inc.\u00a0(NASDAQ: TFFP),\u00a0a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will present a corporate overview at 23<sup>rd<\/sup> H.C. Wainwright Annual Global Investment Conference being held from September 13-15th, 2021.<\/p>\n<p>Details on the presentation can be found below:<\/p>\n<p>Presentation date: available on-demand starting at 7:00 a.m. ET on September 13, 2021<\/p>\n<p>Webcast link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TRwTKLm9xGmrKu1_GvoaCDN1ebJMZboNL205zcuvNYiYE9PI-0wa0FWLq8kqGUjxO8-1OdQ2l1wXVJlVsFlxFYiQv0ql9mqVNegJKhm4Z1zaGS8o6sbMAIoKNdMJhM765w8rgA9vVYfHtDu7E1EtLc8JXO8JCr0OEjL65LhEATcBJrwdekJY9taGYKSSnhys4oln9aO4k4uMIQKDatV9VI_9Eu62ypltOpzm0iaherSaWgnUdNnoXwhuoAmMoMg-n-8OnsPi78J1f-jla5_Wy9-R5FsI9Y57w_Smwg3Y1Y9cpidhWL-sYxNTC8ES7GDFXymosXcJwvmUMhaJr3qICfcnjAPejs-ArzVfI7HluX8civEpsxGkOeoPS55xi62gkAa0y1KoK6yLPYSJ-6CH7ba4E1Stv0sa6ROBL0tO5iMmIdmUfcm9-XUwHNtHtkvIkQ-Uou3p7_R-iEtyfxZQTQ_Q84T59Emnp_vyBWxuR8Rc7ZBaWEQaD9XVvaeIyeeGTOef9CMsvDeL7e1s2Ps1qKjEEQ7Qj3qHpnr_piuaeSTN9JvSZa9dh2KByt770zqy-2B15I9QWrgNwaKeWBHhn8d8A010HlCXXH3qsYkd4nk1eAi_c1uh38AQXJvzrRQR6WnwQ8KoryLMp-DBPXqSHtT8kDWoL780XVBI58NbxNoPAkUgtKHe7SzT2NOYcqAyygMiIdTVZDXhtvcRn0LboRjUn5HrmWeC0w-eyYborYBonswsixYaRdRpUhPzkRX2vV7Rl_Uc8u8KZKG1fzlFNaIKmDYc2QNVE7TxcRgTlaeI0N7_tKU3GGjkq_PEYbNz-FSE7CoyG353puqw40Tlk0xORyLo3zk3wALLv7vkPsz2CEMnrhkDcKk_HsaY6uObnJff5CphGVw5F1Eb21xevA==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/journey.ct.events\/view\/4a77d813-2d0d-4ffe-9b6d-920b5962e6e5<\/a><\/p>\n<p>\n        <strong>About\u00a0TFF Pharmaceuticals\u00a0<\/strong><br \/>\n        <br \/>TFF Pharmaceuticals, Inc.\u00a0is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform can significantly improve the solubility and absorption of poorly water-soluble drugs, a class of drugs that comprises approximately one-third of the major pharmaceuticals worldwide, thereby improving their pharmacokinetics.\u00a0TFF Pharmaceuticals\u00a0has two lead drug candidates: Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder. The Company plans to add to this pipeline by collaborating with large pharmaceutical partners. The TFF Platform is protected by 58 patents issued or pending in the US and internationally. To learn more about\u00a0TFF Pharmaceuticals\u00a0and its product candidates, visit the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TRwTKLm9xGmrKu1_GvoaCGZqNQV3q4g4u-99YxgW9kcTUV17kjWOHw_rp4ZRtNLhgUUtd3_XfrIrMBztngY0Pp6mBsuuPn9bS-i8CP_XVdvYFfMUUssJ7UZ8QOoAEDSSGnuNujqmAFE02QdMbwViFN5_tzs3kZtWIBTWINBi76rp1VSOZY1THvi2MPv51MmgyvHOtgXzQseRD_4UydKD0tpJ-ocWpLc-VsO6k1TDT1EibiZlyVsvol76Bc7TFpzj01E77obXGdHEz5WyNMYJcA==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/tffpharma.com<\/a>.<\/p>\n<p>\n        <strong>Company Contacts:<\/strong>\n      <\/p>\n<p>Glenn Mattes<br \/>President and CEO<br \/>TFF Pharmaceuticals, Inc<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KZlbSaESiez445JlXyNLTDQ_tb6z-NQ51oL0mZhcy8vwD1UV8qX0kWPJfZq_gPW2hTnChNGpT1gatm3R8gi0EDeMCpre8I69_btmVxxliDs=\" rel=\"nofollow noopener\" target=\"_blank\">gmattes@tffpharma.com<\/a>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<br \/>737-802-1973<\/p>\n<p>Kirk Coleman<br \/>Chief Financial Officer<br \/>TFF Pharmaceuticals, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SNwYvWYsDUVuWjMd4a6b38o9SLzDMOUjLIWUsupNzHyFhpysQQ5RO7jUtxI6vNniQPv-QZDix_psoLUi8gE8tjGmOgEG4RNQ9qiGGJTlt2Q=\" rel=\"nofollow noopener\" target=\"_blank\">kcoleman@tffpharma.com<\/a>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<br \/>817-989-6358<\/p>\n<p>\n        <strong>Investor Relations Contact:\u00a0<\/strong>\u00a0<br \/>Corey Davis, Ph.D.\u00a0<br \/>LifeSci Advisors\u00a0<br \/>212-915-2577\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FgGjI-6r8Hd5SbjUBwRLyhggQZ1rCNVRVB0qeR-i1kWTlbRa1G7TGvuT15uLmDUktXPU9Dhl83Q6lGBng5582wb2cFWe69_6e8AKfU4X4R1Al7xaKISzCk13HhZvonFd\" rel=\"nofollow noopener\" target=\"_blank\">cdavis@lifesciadvisors.com<\/a>\u00a0\u00a0<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Gwendolyn Schanker<br \/>LifeSci Communications<br \/>269-921-3607<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bjz-u5CYajtxVw30XAgNuBT-s5J8LFz0V6ArX97xmUxiHPl8o5O7bDuc3Ee53QC8hW8uMUoPO1Z-Z2xXrKU9wbWndczTGLZBMpqjOuA5TGI4kLqoXogzXSKoVSOIORXw\" rel=\"nofollow noopener\" target=\"_blank\">gschanker@lifescicomms.com<\/a>\u00a0<\/p>\n<p>Source: TFF Pharmaceuticals, Inc.<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MTMwZTQ4YWUtMjVlZi00YzJmLWI1NjgtNjkyMjEzZTFjNGQ0LTUwMDA4MDQ2Mg==\/tiny\/TFF-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, Texas, Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; TFF Pharmaceuticals, Inc.\u00a0(NASDAQ: TFFP),\u00a0a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will present a corporate overview at 23rd H.C. Wainwright Annual Global Investment Conference being held from September 13-15th, 2021. Details on the presentation can be found below: Presentation date: available on-demand starting at 7:00 a.m. ET on September 13, 2021 Webcast link: https:\/\/journey.ct.events\/view\/4a77d813-2d0d-4ffe-9b6d-920b5962e6e5 About\u00a0TFF Pharmaceuticals\u00a0 TFF Pharmaceuticals, Inc.\u00a0is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform can &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535876","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas, Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; TFF Pharmaceuticals, Inc.\u00a0(NASDAQ: TFFP),\u00a0a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will present a corporate overview at 23rd H.C. Wainwright Annual Global Investment Conference being held from September 13-15th, 2021. Details on the presentation can be found below: Presentation date: available on-demand starting at 7:00 a.m. ET on September 13, 2021 Webcast link: https:\/\/journey.ct.events\/view\/4a77d813-2d0d-4ffe-9b6d-920b5962e6e5 About\u00a0TFF Pharmaceuticals\u00a0 TFF Pharmaceuticals, Inc.\u00a0is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform can &hellip; Continue reading &quot;TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-08T20:08:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference\",\"datePublished\":\"2021-09-08T20:08:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/\",\"name\":\"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg==\",\"datePublished\":\"2021-09-08T20:08:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference - Market Newsdesk","og_description":"AUSTIN, Texas, Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; TFF Pharmaceuticals, Inc.\u00a0(NASDAQ: TFFP),\u00a0a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will present a corporate overview at 23rd H.C. Wainwright Annual Global Investment Conference being held from September 13-15th, 2021. Details on the presentation can be found below: Presentation date: available on-demand starting at 7:00 a.m. ET on September 13, 2021 Webcast link: https:\/\/journey.ct.events\/view\/4a77d813-2d0d-4ffe-9b6d-920b5962e6e5 About\u00a0TFF Pharmaceuticals\u00a0 TFF Pharmaceuticals, Inc.\u00a0is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform can &hellip; Continue reading \"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-08T20:08:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference","datePublished":"2021-09-08T20:08:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/","name":"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg==","datePublished":"2021-09-08T20:08:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQ0NyM0Mzk1NDk0IzUwMDA4MDQ2Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tff-pharmaceuticals-to-present-at-23rd-h-c-wainwright-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TFF Pharmaceuticals to Present at 23rd H.C. Wainwright Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535876"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535876\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}